These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
204 related articles for article (PubMed ID: 9337349)
1. Cross-reactivity of C219 anti-p170(mdr-1) antibody with p185(c-erbB2) in breast cancer cells: cautions on evaluating p170(mdr-1). Liu B; Sun D; Xia W; Hung MC; Yu D J Natl Cancer Inst; 1997 Oct; 89(20):1524-9. PubMed ID: 9337349 [TBL] [Abstract][Full Text] [Related]
2. Anti-P-glycoprotein antibody C219 cross-reactivity with c-erbB2 protein: diagnostic and clinical implications. Chan HS; Ling V J Natl Cancer Inst; 1997 Oct; 89(20):1473-6. PubMed ID: 9337338 [No Abstract] [Full Text] [Related]
3. Antibody C219 recognizes an alpha-helical epitope on P-glycoprotein. van Den Elsen JM; Kuntz DA; Hoedemaeker FJ; Rose DR Proc Natl Acad Sci U S A; 1999 Nov; 96(24):13679-84. PubMed ID: 10570132 [TBL] [Abstract][Full Text] [Related]
4. Overexpression of c-erbB-2/neu in breast cancer cells confers increased resistance to Taxol via mdr-1-independent mechanisms. Yu D; Liu B; Tan M; Li J; Wang SS; Hung MC Oncogene; 1996 Sep; 13(6):1359-65. PubMed ID: 8808711 [TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical localization in normal tissues of different epitopes in the multidrug transport protein P170: evidence for localization in brain capillaries and crossreactivity of one antibody with a muscle protein. Thiebaut F; Tsuruo T; Hamada H; Gottesman MM; Pastan I; Willingham MC J Histochem Cytochem; 1989 Feb; 37(2):159-64. PubMed ID: 2463300 [TBL] [Abstract][Full Text] [Related]
6. [Eukaryotic expression and biological activities of anti-p185 erbB2 mouse/human chimeric antibody]. Jiang BH; Liu WB; Meng L; Wu J; Shou CC Beijing Da Xue Xue Bao Yi Xue Ban; 2004 Oct; 36(5):491-5. PubMed ID: 15489929 [TBL] [Abstract][Full Text] [Related]
7. A new mdr-1 encoded P-170 specific monoclonal antibody: (6/1C) on paraffin wax embedded tissue without pretreatment of sections. Moran E; Larkin A; Doherty G; Kelehan P; Kennedy S; Clynes M J Clin Pathol; 1997 Jun; 50(6):465-71. PubMed ID: 9378810 [TBL] [Abstract][Full Text] [Related]
8. Cell surface density of p185(c-erbB-2) determines susceptibility to anti-p185(c-erbB-2)-ricin A chain (RTA) immunotoxin therapy alone and in combination with anti-p170(EGFR)-RTA in ovarian cancer cells. Dean GS; Pusztai L; Xu FJ; O'Briant K; DeSombre K; Conaway M; Boyer CM; Mendelsohn J; Bast RC Clin Cancer Res; 1998 Oct; 4(10):2545-50. PubMed ID: 9796989 [TBL] [Abstract][Full Text] [Related]
9. Analysis of a novel cDNA encoding a C219-reactive peptide isolated from methotrexate-selected multidrug-resistant human leukemic cells. Norris MD; Gilbert J; Madafiglio J; Haber M Gene; 1995 Apr; 156(2):313-4. PubMed ID: 7758977 [TBL] [Abstract][Full Text] [Related]
10. P-glycoprotein of blood brain barrier: cross-reactivity of Mab C219 with a 190 kDa protein in bovine and rat isolated brain capillaries. Beaulieu E; Demeule M; Pouliot JF; Averill-Bates DA; Murphy GF; Béliveau R Biochim Biophys Acta; 1995 Jan; 1233(1):27-32. PubMed ID: 7833346 [TBL] [Abstract][Full Text] [Related]
11. Generation of a monoclonal antibody to P-glycoprotein peptides using tuberculin-PPD as a carrier. Bashir I; Sikora K; Foster CS Virchows Arch; 1998 Mar; 432(3):279-87. PubMed ID: 9532008 [TBL] [Abstract][Full Text] [Related]
12. Immunocytochemical detection of the p170 multidrug resistance (MDR) and the p53 tumor suppressor gene proteins in human breast cancer cells: clinical and therapeutical significance. Bodey B; Bodey B; Gröger AM; Luck JV; Siegel SE; Taylor CR; Kaiser HE Anticancer Res; 1997; 17(2B):1311-8. PubMed ID: 9137491 [TBL] [Abstract][Full Text] [Related]
13. Activation state-specific monoclonal antibody detects tyrosine phosphorylated p185neu/erbB-2 in a subset of human breast tumors overexpressing this receptor. DiGiovanna MP; Stern DF Cancer Res; 1995 May; 55(9):1946-55. PubMed ID: 7728765 [TBL] [Abstract][Full Text] [Related]
14. Heregulin and agonistic anti-p185(c-erbB2) antibodies inhibit proliferation but increase invasiveness of breast cancer cells that overexpress p185(c-erbB2): increased invasiveness may contribute to poor prognosis. Xu FJ; Stack S; Boyer C; O'Briant K; Whitaker R; Mills GB; Yu YH; Bast RC Clin Cancer Res; 1997 Sep; 3(9):1629-34. PubMed ID: 9815853 [TBL] [Abstract][Full Text] [Related]
15. Overexpression of the c-erbB-2 gene enhanced intrinsic metastasis potential in human breast cancer cells without increasing their transformation abilities. Tan M; Yao J; Yu D Cancer Res; 1997 Mar; 57(6):1199-205. PubMed ID: 9067293 [TBL] [Abstract][Full Text] [Related]
16. Multidrug resistance P-glycoprotein monoclonal antibody JSB-1 crossreacts with pyruvate carboxylase. Rao VV; Anthony DC; Piwnica-Worms D J Histochem Cytochem; 1995 Dec; 43(12):1187-92. PubMed ID: 8537634 [TBL] [Abstract][Full Text] [Related]
17. Immunocytochemical observation of multidrug resistance (MDR) p170 glycoprotein expression in human osteosarcoma cells. The clinical significance of MDR protein overexpression. Bodey B; Taylor CR; Siegel SE; Kaiser HE Anticancer Res; 1995; 15(6B):2461-8. PubMed ID: 8669809 [TBL] [Abstract][Full Text] [Related]
18. Isoform I (mdr3) is the major form of P-glycoprotein expressed in mouse brain capillaries. Evidence for cross-reactivity of antibody C219 with an unrelated protein. Jetté L; Pouliot JF; Murphy GF; Béliveau R Biochem J; 1995 Feb; 305 ( Pt 3)(Pt 3):761-6. PubMed ID: 7848274 [TBL] [Abstract][Full Text] [Related]
19. Flow cytometric analysis of multidrug-resistance-associated antigen (P-glycoprotein) and DNA ploidy in human colon cancer. Danova M; Giordano M; Erba E; Palmeri S; Candiloro V; Riccardi A; Ucci G; Mazzini G; D'Incalci M; Ascari E J Cancer Res Clin Oncol; 1992; 118(8):575-80. PubMed ID: 1355483 [TBL] [Abstract][Full Text] [Related]
20. P-glycoprotein epitope mapping. I. Identification of a linear human-specific epitope in the fourth loop of the P-glycoprotein extracellular domain by MM4.17 murine monoclonal antibody to human multi-drug-resistant cells. Cianfriglia M; Willingham MC; Tombesi M; Scagliotti GV; Frasca G; Chersi A Int J Cancer; 1994 Jan; 56(1):153-60. PubMed ID: 7505264 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]